NO20076391L - Sammensetninger og metoder for behandling av tilstander relatert til efrinsignaler med cupredoxin - Google Patents
Sammensetninger og metoder for behandling av tilstander relatert til efrinsignaler med cupredoxinInfo
- Publication number
- NO20076391L NO20076391L NO20076391A NO20076391A NO20076391L NO 20076391 L NO20076391 L NO 20076391L NO 20076391 A NO20076391 A NO 20076391A NO 20076391 A NO20076391 A NO 20076391A NO 20076391 L NO20076391 L NO 20076391L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- methods
- efrine
- cupredoxin
- signals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68281205P | 2005-05-20 | 2005-05-20 | |
US11/244,105 US7691383B2 (en) | 2004-10-07 | 2005-10-06 | Cupredoxin derived transport agents and methods of use thereof |
US76474906P | 2006-02-03 | 2006-02-03 | |
PCT/US2006/019684 WO2007018671A2 (fr) | 2005-05-20 | 2006-05-19 | Compositions et methodes de traitement d'etats associes a la signalisation de l'ephrine au moyen de cupredoxines |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20076391L true NO20076391L (no) | 2008-02-15 |
Family
ID=37727776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20076391A NO20076391L (no) | 2005-05-20 | 2007-12-11 | Sammensetninger og metoder for behandling av tilstander relatert til efrinsignaler med cupredoxin |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1888106A4 (fr) |
JP (1) | JP2008539795A (fr) |
KR (1) | KR20080040631A (fr) |
AU (1) | AU2006277009A1 (fr) |
BR (1) | BRPI0612424A2 (fr) |
CA (1) | CA2608512A1 (fr) |
IL (1) | IL187138A0 (fr) |
MX (1) | MX2007014598A (fr) |
NO (1) | NO20076391L (fr) |
WO (1) | WO2007018671A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
AU2005327535A1 (en) | 2004-10-07 | 2006-08-24 | Ananda Chakrabarty | Cupredoxin derived transport agents and methods of use thereof |
AU2006284490A1 (en) * | 2005-07-19 | 2007-03-01 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to control angiogenesis with cupredoxins |
WO2007012004A2 (fr) | 2005-07-19 | 2007-01-25 | The Board Of Trustees Of The University Of Illinois | Agents de transport utiles pour traverser la barriere hemato-encephalique et pour penetrer dans les cellules cancereuses du cerveau, methodes d'utilisation de ces derniers |
CN101595124A (zh) * | 2006-09-14 | 2009-12-02 | 伊利诺斯大学理事会 | 使用铜氧还蛋白预防癌症的组合物及方法 |
EP2117573A4 (fr) * | 2007-01-11 | 2011-02-16 | Univ Illinois | Compositions et méthodes permettant de traiter des affections associées à la signalisation de l'éphrine avec des cuprexodines et des mutants de celles-ci |
TWI443109B (zh) | 2007-08-30 | 2014-07-01 | Daiichi Sankyo Co Ltd | 抗epha2抗體 |
KR101102829B1 (ko) * | 2008-09-12 | 2012-01-05 | 재단법인 제주테크노파크 | 구멍갈파래 추출물과 그것의 항염증제로서의 용도 |
CN110090295B (zh) * | 2018-01-29 | 2022-12-23 | 武汉康理通科技有限公司 | Ephrin-B1在制备治疗炎症性肠病的药物中的用途 |
WO2023205752A2 (fr) * | 2022-04-22 | 2023-10-26 | University Of Miami | Peptides mimétiques de ligand d'éphrine pour le traitement de maladies neurodégénératives |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2436224A1 (fr) * | 2001-02-15 | 2002-10-03 | The Board Of Trustees Of The University Of Illinois | Facteurs cytotoxiques destines a moduler la mort cellulaire |
US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
-
2006
- 2006-05-19 JP JP2008512587A patent/JP2008539795A/ja active Pending
- 2006-05-19 EP EP06813192A patent/EP1888106A4/fr not_active Withdrawn
- 2006-05-19 KR KR1020077028984A patent/KR20080040631A/ko not_active Application Discontinuation
- 2006-05-19 WO PCT/US2006/019684 patent/WO2007018671A2/fr active Application Filing
- 2006-05-19 CA CA002608512A patent/CA2608512A1/fr not_active Abandoned
- 2006-05-19 MX MX2007014598A patent/MX2007014598A/es active IP Right Grant
- 2006-05-19 BR BRPI0612424-0A patent/BRPI0612424A2/pt not_active IP Right Cessation
- 2006-05-19 AU AU2006277009A patent/AU2006277009A1/en not_active Abandoned
-
2007
- 2007-11-04 IL IL187138A patent/IL187138A0/en unknown
- 2007-12-11 NO NO20076391A patent/NO20076391L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2608512A1 (fr) | 2007-02-15 |
AU2006277009A1 (en) | 2007-02-15 |
JP2008539795A (ja) | 2008-11-20 |
WO2007018671A3 (fr) | 2007-11-22 |
EP1888106A2 (fr) | 2008-02-20 |
MX2007014598A (es) | 2008-02-07 |
WO2007018671A2 (fr) | 2007-02-15 |
BRPI0612424A2 (pt) | 2009-01-27 |
EP1888106A4 (fr) | 2009-01-14 |
IL187138A0 (en) | 2008-02-09 |
KR20080040631A (ko) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20076391L (no) | Sammensetninger og metoder for behandling av tilstander relatert til efrinsignaler med cupredoxin | |
NO20091326L (no) | Indazolderivater som modulatorer av interleukin-1-reseptor-assosiert kinase | |
NO20170633A1 (no) | Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff . | |
NO20064976L (no) | Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser | |
BRPI0923786C1 (pt) | compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos e composições farmacêuticas compreendendo ditos compostos | |
ME01285A (me) | Derivati dioksa-bicikl0[3.2.1]oktan-2,3,4-triola | |
MY163477A (en) | Pyrimidinyl-pyridazinone derivatives | |
MX2009004986A (es) | Metodos de tratamiento de anemia hemolitica. | |
DE602004006433D1 (de) | Pyrrol-substituierte indole als inhibitoren von pai-1 | |
NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
NO20052595L (no) | Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser. | |
NO20083501L (no) | Azaindoler som er anvendelige som inhibitorer for Janus-kinaser | |
NO20073628L (no) | Pyridoner som er nyttige som inhibitorer av kinaser | |
NO20061194L (no) | Mitotiske kinesininbibitorer | |
NO20071619L (no) | Fremgangsmate for fremstilling av indazol forbindelse | |
NO20082509L (no) | Pyridopyrazinderivater og deres anvendelse | |
MX354402B (es) | Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos. | |
EA200601894A1 (ru) | Производные пиперазинилпиперидина в качестве антагонистов хемокинового рецептора | |
WO2010031056A3 (fr) | Procédés et compositions pour moduler l'activité ire1, src, et abl | |
NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
WO2007111948A3 (fr) | Inhibiteurs de prényltransférases protéiques | |
EA200601279A1 (ru) | Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина | |
NO20092130L (no) | Tricykliske heteroarylforbindelser anvendelige som inhibitorer of januskinase | |
EA201270325A1 (ru) | Способы лечения саркомы с использованием эпиметаболической сдвигающей добавки (кофермента q10) | |
NO20092073L (no) | Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |